The global liver health supplements market size was valued at USD 707.16 million in 2018 and is expected to register a CAGR of 4.32% during the forecast period. In recent years, changing lifestyle pattern has led to a rise in consumption of fast food and alcohol, contributing to the high...Read More »
December : 2019The global Hunter syndrome treatment market size was valued at USD 864.9 million in 2018 and is expected to witness attractive growth over the forecast period. Introduction of novel therapies, robust product pipeline, rising government initiatives, and increasing awareness regarding Hunt...Read More »
November : 2019The global hyaluronidase market size was estimated at USD 648.11 million in 2018 and is projected to grow at a CAGR of 8.55% during the forecast period. Rising penetration across various application areas and the presence of several clinical studies to demonstrate the efficacy of the pro...Read More »
November : 2019The Asia Pacific nutritional supplements market size was estimated at USD 107.5 billion in 2018 and is projected to grow at a CAGR of 6.46% over the forecast period. The market is primarily driven by expanding GDP and growing geriatric population. Increasing number of product launch...Read More »
November : 2019The global intravenous iron drugs market size was estimated at USD 1.63 billion in 2018 and is anticipated to grow at a CAGR of 7.2% over the forecast period. Growing prevalence of chronic kidney disease, increasing number of patients undergoing dialysis, and rising geriatric population ...Read More »
October : 2019The global somatostatin analogs market size was valued at USD 5.5 Billion in 2018 and is expected to grow at a CAGR of 6.3% over the forecast period. Increasing prevalence of Neuroendocrine Tumors (NETs), acromegaly, Cushing syndrome and other related diseases is expected to accelerate g...Read More »
October : 2019The global myasthenia gravis (MG) treatment market size was estimated at USD 1.16 billion in 2018 and is anticipated to grow at a CAGR of 7.5% over the forecast period. The key factors driving this market include the rising adoption of immunotherapies, approval of promising drugs, emerge...Read More »
October : 2019The global non-opioid pain patches market size was valued at USD 732.6 million in 2018 and is expected to grow at a CAGR of 4.6% during the forecast period. Global rise in chronic and acute pain related disorders and various benefits associated with non-opioid pain patches over conventio...Read More »
October : 2019The global organ transplant immunosuppressant drugs market size was estimated at USD 4.64 billion in 2018 and is anticipated to grow at a CAGR of 3.3% over the forecast period. Increasing demand for transplantations and technological advancements in organ transplants & tissue enginee...Read More »
October : 2019The global neglected tropical disease (NTD) treatment market size was valued at USD 1.2 billion in 2018 and is expected to grow at a CAGR of 5.5% over the forecast period. Formal recognition of NTDs in the Sustainable Development Goals (SDG), a United Nations Development P...Read More »
October : 2019The global amyotrophic lateral sclerosis treatment market size was estimated at USD 537.2 million in 2018 and is anticipated to grow at a CAGR of 5.8% over the forecast period. Rising geriatric population, growing awareness about ALS, and increasing incidence rate are the factors driving...Read More »
October : 2019The global enzyme replacement therapy market size was estimated at USD 6.74 billion in 2018 and is anticipated to witness a CAGR of 7.7% during the forecast period. The rising availability of enzyme replacement therapies, increasing awareness, and less stringent guidelines for rare disea...Read More »
October : 2019The global ophthalmic packaging market size was valued at USD 7.1 billion in 2018 and is projected to expand at a CAGR of 9.9% by 2026. Rising need for brand enhancement and differentiation in an increasingly competitive environment coupled with high prevalence of eye disorders are some ...Read More »
October : 2019The global skeletal dysplasia market size was valued at USD 2.5 billion in 2018 and is expected to exhibit a CAGR of 4.0% over the forecast period. Skeletal dysplasia includes around 400 conditions affecting bone development, including cartilage growth and neurological functioning. Accor...Read More »
October : 2019The global supplements and nutrition packaging market size was valued at USD 21.9 billion in 2018 and is expected to expand at a CAGR of 3.6% during the forecasting period. High consumption of nutrition supplements owing to growing awareness about health and fitness, coupled with rising ...Read More »
October : 2019The global inhalable drugs market size was valued at USD 25.0 billion in 2018 and is estimated to exhibit a CAGR of 6.3%during the forecast period. Increasing prevalence of respiratory diseases such as Chronic Obstructive Pulmonary Diseases (COPD), asthma, and cystic fibrosis is anticipa...Read More »
October : 2019The global lymphoma treatment market size was valued at USD 11.7 billion in 2018 and is anticipated to grow at a CAGR of 9.5% over the forecast period. Growing uptake of premium-priced products such as immune checkpoint inhibitors, Keytruda, and Opdivo is driving the market.In addition, ...Read More »
October : 2019The global retinal disorder treatment market size was valued at USD 8.8 billion in 2018 and is expected to register a CAGR of 7.6% over the forecast period. Market growth can be primarily attributed to increased funding by regulatory bodies for conducting research on ocular disorders.&nb...Read More »
October : 2019The Missouri medical cannabis market size is anticipated to be valued at USD 31.1 million in 2020 and is projected to register a CAGR of 22.0% over the forecast period. Medical use of cannabis was legalized in Missouri in 2018 and the commercialization is expected to begin from 2020. Gro...Read More »
October : 2019The global T-cell Therapy market size was worth 2.4 billion in 2018 and is projected to expand at a CAGR of 15.4% during the forecast period. With the approval of Kymriah and Yescarta, several companies have shifted their business models from developing small molecule and protein-based t...Read More »
September : 2019The global food allergy diagnostics & therapeutics market size was valued at USD 2.69 billion in 2018 and is expected to grow at a lucrative CAGR of 7.4% over the forecast period. Rising prevalence of food allergy is anticipated to drive the market. Symptoms associated with allergic ...Read More »
September : 2019The U.S. prostate cancer nuclear medicine diagnostics market size was valued at USD 172.2 million in 2018 and is estimated to expand at a CAGR of 10.7% during the forecast period. Rising incidence of prostate cancer is expected to impel the demand for early and accurate diagnosis of the ...Read More »
September : 2019The global cannabis cultivation market size was valued at USD 15.7 billion in 2018 and is anticipated to exhibit a CAGR of 13.5%. Legalization of cannabis for medical & recreational purposes in North America & Europe and growing demand for marijuana-based products among patients ...Read More »
August : 2019The global women’s health market size was valued at USD 39.3 billion in 2018 and is expected to grow at a CAGR of 4.2% over the forecast period. Increase in population of geriatric women, rise in adoption of an unhealthy lifestyle, and introduction of novel medicines for women can ...Read More »
August : 2019The global anterior uveitis treatment market size was valued at USD 276.78 million in 2018 and is expected to witness a CAGR of 5.4% over the forecast period. Rising incidence of anterior uveitis is majorly driving growth. This disease causes inflammation in anterior part of the uvea of ...Read More »
August : 2019The global HPV associated disorders market size was estimated at USD 16.34 billion in 2018 and is expected to exhibit a CAGR of 4.5% during the forecast period. Growing prevalence of HPV-related diseases and increasing penetration of treatment options are expected to drive the market. Th...Read More »
August : 2019The global aromatherapy carrier oil market size was valued at USD 898.03 million in 2018 and is expected to grow at a lucrative CAGR of 10.0% over the forecast period. Increase in preference for plant extracted products is one of the major factors driving the market. Carrier oils are veg...Read More »
August : 2019The New York cannabis market size was valued at USD 1.8 billion in 2018 and is estimated to register a CAGR of 14.7% over the forecast period. Use of cannabis has been legalized in the state of New York for medical purposes, while recreational use of cannabis is expected to be legalized ...Read More »
July : 2019The global cold pain therapy market size was valued at USD 1.6 billion in 2018 and is expected to grow at a CAGR of 4.9% during the forecast period. Rising prevalence of orthopedic diseases and increasing number of sports injuries have led to a high growth of the market.According to 2017...Read More »
July : 2019The global opioid use disorder market size was valued at USD 1.9 billion in 2018 and is anticipated to grow at a CAGR of 10.1% over the forecast period. Increase in opioid epidemic in the U.S. coupled with establishment of government policies to control the crisis is driving the market.O...Read More »
July : 2019The U.S. aromatherapy market size was valued at USD 469.93 million in 2018 and is anticipated to exhibit a CAGR of 9.1% over the forecast period. Growing awareness about therapeutic benefits of essential oils is one of the primary drivers. Essential oils have varied applications. They ar...Read More »
July : 2019The global interleukin inhibitors market size was estimated at USD 20.7 billion in 2018 and is expected to exhibit a CAGR of 17.4% during the forecast period. Growing prevalence of autoimmune diseases and increasing adoption of interleukin inhibitors are expected to drive the IL Inhibito...Read More »
July : 2019The global heparin market size was estimated at USD 6.49 billion in 2018and is projected to expand at a CAGR of 1.6%. Increasing number of accidents and surgeries is expected to be a key driver for the growth. Increasing incidence of venous thromboembolism and cardiovascular disorders is...Read More »
July : 2019The global hereditary angioedema therapeutic market size was valued at USD 2.3 billion in 2018. Growing cases of hereditary angioedema (HAE) globally is a key market driver. According to the National Organization for Rare Disorders (NORD), about 1-9 people per 100,000 population are affe...Read More »
July : 2019The global scleroderma therapeutics market size was valued at USD 1.60 billion in 2018 and is estimated to expand at a CAGR of 6.0% from 2019 to 2026. The market is mainly driven by the off-label use of drugs approved for its symptomatic indications, such as rheumatoid arthritis. Lack of...Read More »
July : 2019The global tumor necrosis factor inhibitor drugs market size was valued at USD 40.4 billion in 2018 and is estimated to expand at a CAGR of 0.5% over the forecast period. The growth is expected to be driven by new product launches, promising pipeline, increasing incidence of autoimmune d...Read More »
July : 2019The global irritable bowel syndrome treatment market size was valued at USD 1.5 billion in 2018 and is anticipated to exhibit a CAGR of 10.1% over the forecast period. Rising prevalence of target disease, coupled with increasing uptake of drugs for the same, is driving the market.Further...Read More »
July : 2019The global phenylketonuria treatment market size was valued at USD 445.8 million in 2018 and is expected to register a CAGR of 11.0% from 2019 to 2026. Increasing prevalence of PKU across the globe is estimated to accelerate the market growth. According to the Genetic Home Reference, 1 i...Read More »
July : 2019The global anti-acne cosmetics market size was valued at USD 2.07 billion in 2018 and is expected to expand at a CAGR of 8.2% during the forecast period. The negative social stigma associated with acne and rising consumption of cosmetics by both men and women, especially from the emergin...Read More »
July : 2019The global alopecia market size was valued at USD 2.5 billion in 2018 and is expected to expand at a CAGR of 8.3% over the forecast period. One of the key factors contributing to revenue growth is increasing prevalence of alopecia areata and androgenetic alopecia. Rise in incidence of Po...Read More »
July : 2019The global mineral supplements market size was valued at USD 10.26 billion in 2018 and is anticipated to expand at a CAGR of 5.1% over the forecast period. Rising prevalence of mineral deficiencies, especially calcium, zinc, and iron, and growing awareness regarding health and fitness ar...Read More »
July : 2019The global uveitis treatment market size was valued at USD 493.91 million in 2018 and is expected to witness lucrative CAGR of 5.8% over the forecast period. Rising incidence of uveitis is the major factor driving the growth. According to The College of Optometrists, the incidence of ant...Read More »
July : 2019The global psoriatic arthritis treatment market size was valued at USD 8.6 billion in 2018 and is estimated to expand at a CAGR of 10.1% over the forecast period. Promising pipeline, new product launches, increasing disease burden, and a significant rise in consumer awareness are some of...Read More »
July : 2019The global cannabidiol market size was estimated at USD 1.34 billion in 2018 and is expected to expand at a CAGR of 32.6% over the forecast period. Increasing awareness regarding health benefits pertaining to cannabidiol consumption is projected to foster the growth. High demand for cann...Read More »
July : 2019The global idiopathic pulmonary fibrosis treatment market size was valued at USD 2.00 billion in 2018 and is estimated to expand at a CAGR of 12.7% over the forecast period. Increasing prevalence of idiopathic pulmonary fibrosis (IPF) and increasing geriatric population are the key drive...Read More »
July : 2019The U.S. cannabis market size was valued at USD 11.3 billion in 2018 and is expected to register a lucrative CAGR of 14.5% over the forecast period. Cannabis, or marijuana, is very commonly used in the U.S. by cosmetic, pharmaceutical, and food and beverage industries. The market has bee...Read More »
July : 2019The Mexico medical cannabis market size was valued at USD 47.3 million in 2018 and is anticipated to register a CAGR of 27.7% over the forecast period. Growing adoption of medical marijuana for the treatment of chronic conditions such as cancer, neurological diseases, and chronic pain is...Read More »
June : 2019The global cancer supportive care drugs market size was valued at USD 21.1 billion in 2018. It is projected to exhibit a CAGR of 1.0% during the forecast period. Large number of side-effects associated with cancer treatment, increasing uptake of biosimilars, rising expenditure on healthc...Read More »
June : 2019The global inflammatory bowel disease treatment market size was valued at USD 15.9 billion in 2018 and is expected to register a CAGR of 4.4% from 2018 to 2026. Presence of strong pipeline products for the treatment of inflammatory bowel disease (IBD) is anticipated to drive the market o...Read More »
June : 2019The global actinic keratosis treatment market size was valued at USD 6.3 billion in 2018 and is estimated to expand at a CAGR of 4.8% over the forecast period. Increase in disease prevalence, aided by environmental factors, such as ozone depletion and excessive sun exposure, is one of th...Read More »
June : 2019The global skin antiseptic products market size was valued at USD 192.25 million in 2018 and is expected to register a CAGR of 6.9% from 2019 to 2026. Product demand is increasing due to rising prevalence of Hospital Acquired Infections (HAIs), due to lack of sanitation and precaution, a...Read More »
June : 2019The global antisense & RNAi therapeutics market size was estimated at USD 1.09 billion in 2018 and is expected to witness a CAGR of 7.5% during the forecast period. Antisense technology provides the opportunity to manipulate the gene expression and this is being considered as an effe...Read More »
June : 2019The global personalized medicine (PM) market size was estimated at USD 1.57 trillion in 2018 and is anticipated to expand at a CAGR of 10.6% during the forecast period. Personalized medicine promises a paradigm shift in diagnosis and care delivery as the treatment is based on data levera...Read More »
June : 2019The global medical writing market size was valued at USD 1.72 billion in 2018 and is expected to witness a CAGR of 10.3% from 2019 to 2026. The FDA Biologic License Application (BLA) and NeMedical Writing Market Size, Share & Trends Analysis Report By Application (Medical Journalism,...Read More »
June : 2019The global allergy diagnostics and therapeutics market size was valued at USD 32.06 billion in 2018 and is anticipated to expand further at a strong CAGR of 6.3% over the forecast period. Increasing incidences of allergic diseases coupled with high demand for in vitro diagnostic blood te...Read More »
June : 2019The global legal marijuana market size was estimated at USD 13.8 billion in 2018 and is projected to expand at a CAGR of 23.9% by 2025. Growing legalization in various countries is primarily driving the market. Furthermore, rising adoption of cannabis as a medical product for treating co...Read More »
May : 2019The global cannabis extract market size was estimated at USD 5.3 billion in 2018 and is projected to exhibit a CAGR of 22.1% over the forecast period. Growing adoption of medical marijuana for the treatment of chronic diseases such as cancer, arthritis, and Alzheimer’s, as well as ...Read More »
May : 2019The global nutritional supplements market size was valued at USD 273.9 billion in 2018 and is anticipated to expand at a CAGR of 6.4% over the forecast period. Rising health consciousness and growing consumer interest in active living are some of the major factors driving the market. Acc...Read More »
May : 2019The global hemoglobinopathies market size was valued at USD 5.8 billion in 2018 and is expected to expand at a CAGR of 10.2% during the forecast period. Increasing cases of hemoglobinopathies, especially in regions such as Southeast Asia and Africa, is one of the major growth drivers. Ac...Read More »
May : 2019The global aromatherapy market size was valued at USD 1.3 billion in 2018 and is projected to witness 10.4% CAGR over the forecast period. Rising awareness about therapeutic uses of essential oils is anticipated to drive the growth. Aromatherapy is an alternative medicine therapy used to...Read More »
April : 2019The global inhalation anesthesia market size was valued at nearly USD 1.12 billion in 2018 and is expected to expand at a CAGR of 3.5% during the forecast period. Rapid rise in aging population suffering from cancer, cardiovascular, spinal, orthopedic, respiratory, gastrointestinal, neur...Read More »
April : 2019The global pulmonary arterial hypertension market size was valued at USD 6.0 billion in 2018 and is expected to register a CAGR of 5.6% over the forecast period. Changing consumer lifestyle, along with increasing geriatric population, is expected to drive the growth. Supportive gove...Read More »
April : 2019The global ophthalmic drugs market size was valued at USD 30.30 billion in 2018 and is expected to grow at a CAGR of 4.5% from 2018 to 2026. Increased funding by public and private bodies for conducting research on ocular disorders along with the presence of strong emerging pipeline drug...Read More »
April : 2019The global opioids market size was valued at USD 25.4 billion in 2018 and is projected to expand at a CAGR of 1.8% during the forecast period. Increasing prevalence of diseases that cause chronic pain, such as cancer, postsurgical pain, lower back pain, fibromyalgia, and arthritis, is dr...Read More »
April : 2019The global biodefense market size was valued at USD 5.47 billion in 2018 and is anticipated to expand at a CAGR of 4.5 % over the forecast period. Rising government initiatives aimed at enhancing the preparedness against Chemical, Biological, Radiological and Nuclear (CBRN) threats is a ...Read More »
April : 2019The global pharmaceutical analytical testing outsourcing market size was valued at USD 5.59 billion in 2018. The market is projected to expand further at a strong CAGR of 8.1% from 2019 to 2026. Increasing demand for biopharmaceuticals, bio-similar, and analytical drugs is projected to b...Read More »
April : 2019The global enteral feeding formulas market size was valued at USD 5.32 billion in 2018 and is anticipated to register a 7.2% CAGR over the forecast period. Rise in prevalence of chronic diseases such as cancer, stroke, multiple sclerosis, dementia, chronic liver disease, Chronic Obstruct...Read More »
April : 2019The global medical foods market size was valued at USD 17.15 billion in 2018 and is anticipated to register a CAGR of 6.7% over the forecast period. Increasing geriatric population, burden of chronic diseases, and awareness about clinical nutrition among healthcare professionals and pati...Read More »
March : 2019The global complementary and alternative medicine market size was valued at USD 59.76 billion in 2018 and is anticipated to expand at a CAGR of 17.07% during the forecast period. Increasing awareness regarding traditional therapy methods is projected to drive the growth. In 2018, it was ...Read More »
March : 2019The global anti-infective agents market size was valued at USD 111.1 billion in 2018 and is anticipated to expand at a CAGR of 3.4% during the forecast period. Extensive R&D efforts pertaining to the development of new drugs with high efficacy and potency against multi-drug resistant...Read More »
March : 2019Neglected tropical diseases drugs and vaccines market comprise diseases that affect largely developing countries but due to increased international migration, these diseases are now a concern in developed nations. The London Declaration, signed in 2012, aimed to bring in focus neglected ...Read More »
The global parenteral nutrition market size was valued at USD 5.3 billion in 2018 and is expected to exhibit a CAGR of 5.8% over the forecast period. Presence of a large number of malnourished children, high natality rate around the globe, increasing premature births, rising occurrence o...Read More »
March : 2019The global bioanalytical testing services market size was valued at USD 2.67 billion in 2018 and is expected to register a CAGR of 7.5% over the forecast period. Increasing frequency of outsourcing R&D activities by the major pharmaceutical companies to focus on their core competenci...Read More »
March : 2019The global Active Pharmaceutical Ingredient (API) market size was valued at USD 158.15 billion in 2018 and is estimated to expand at a CAGR of 6.8% over the forecast years. Advancements in API manufacturing and growth of biopharmaceutical sector are expected to be the key factors driving...Read More »
March : 2019The global hemophilia market was valued at USD 11.1 billion in 2018 and is expected to grow at a CAGR of 5.2% over the forecast period. The Presence of limited therapies and rising burden over the regulatory authorities toward treatment of these disorders is expected to drive R&D foc...Read More »
February : 2019The global anti-aging services market size was valued at USD 23.45 billion in 2018. It is poised to expand at a CAGR of 5.3% over the forecast period. The market has been shaped by constantly changing customer demands. Since majority of customer base in the market has become social media...Read More »
February : 2019The global cancer immunotherapymarket size was valued at USD 58.1 Billion in 2018. Growing adoption of advanced cancer therapeutic options coupled with rising cancer incidence has been one of the primary growth stimulants for the market. Healthcare providers are focusing on improving can...Read More »
February : 2019The global acromegaly treatment market size was estimated at USD 1.2 billion in 2018 and is expected to exhibit a CAGR of 7.5% during the forecast period. Increasing incidence of the disease is contributing to the high demand for the advanced treatment options which further boost the dev...Read More »
February : 2019The global antibiotics market size was valued at USD 45.31 billion in 2018 and is projected to expand at a CAGR of 4.0% over the forecast period. Rise in the cases of infectious diseases along with imbalance of demand-supply of antibiotics is the main factor driving the growth this marke...Read More »
February : 2019The global breast cancer drugs market size was valued at USD 16.98 billion in 2017 and is expected to register at a CAGR of 10.7% over the forecast period. Rising prevalence of the disease along with emerging novel therapies are some of the major factors likely to drive the market. Early...Read More »
February : 2019The global attention deficit hyperactivity disorder market size was valued at USD 16.4 billion in 2018 and is estimated to exhibit a CAGR of 6.4% over the forecast period. Product launches across the globe, approval of new drugs, and increased research and development activities are like...Read More »
February : 2019The global cold plasma market size was valued at USD 55.84 million in 2017 and is expected to register a CAGR of 15.2% over the forecast period. Demand for cold plasma is increasing due to its extensive usage in medical treatment. In addition, rising cases of Hospital-Acquired Infec...Read More »
January : 2019The global biopharmaceutical third party logistics market size was estimated at USD 86.37 billion in 2018 and is projected to expand at a CAGR of 4.9% over the forecast period. Rising trend of outsourcing logistics, growth in pharmaceutical distribution network owing to its strong sales ...Read More »
January : 2019The global pharmaceutical grade lactose market size was estimated at USD 177.6 million in 2017, and is expected to expand at a CAGR of 4.6% over the forecast period. Growing product demand in infant formulation, owing to its excellent characteristics including iron absorption, immune cel...Read More »
January : 2019The global epigenetics drugs and diagnostic technologies market size was valued at USD 5.24 billion in 2017 and is projected to expand at a CAGR of 19.7% over the forecast period. High prevalence of cancer and other chronic diseases along with rising geriatric population are some of the ...Read More »
January : 2019The global metabolic disorder therapeutics market size was valued at USD 49.65 billion in 2017 and is expected to register a CAGR of 7.56% over the forecast period. Increasing demand for one-time therapies for metabolic disorders and rising prevalence of lifestyle diseases are the key fa...Read More »
January : 2019The global biopharmaceutical excipients market size was valued at USD 1.67 billion in 2017.It is poised to witness a CAGR of 6.08% during the forecast period. The stability of large molecules is inherently less, as compared to small molecules. Research and investments made to address the...Read More »
January : 2019The global Fabry disease treatment market size was valued at USD 1.57 billion in 2017. It is anticipated to progress at a CAGR of 9.6% over the forecast period. Expanding base of patients suffering with Fabry disease coupled with increased adoption of novel therapies such as chaperone tr...Read More »
January : 2019The global antibody drug conjugates market size was valued at USD 1.57 billion in 2017 and is projected to register a CAGR of 25.9% over the forecast period. Major advancements in linker technology coupled with extensive R&D activities is likely to drive the market. Antibody Drug Con...Read More »
January : 2019The global antacids market size was valued at USD 5.83 billion in 2017 and is projected to expand at a CAGR of 3.9% over the forecast period. Changing dietary habits is one of the major factors expected to fuel the growth during the forecast period. Increasing prevalence of Gastro ...Read More »
January : 2019The global diabetic foot ulcer treatment market size was valued at USD 3.6 billion in 2017. It is anticipated to expand at a CAGR of 8.2% over the forecast period. Rising prevalence of diabetes and rapidly growing geriatric population worldwide are among the primary growth stimulants for...Read More »
January : 2019The global nasal drug delivery technology market size was valued at USD 41.01 billion in 2017 and is projected to expand at a CAGR of 6.5% over the forecast period. Increasing preference for alternative mode of drug administration is one of the major factors expected to fuel the market g...Read More »
January : 2019The global rosacea treatment market size was valued at USD 1.5 billion in 2017. It is anticipated to register a CAGR of 6.8% over the forecast period. The market is consolidated in nature. Proactive government initiatives, advanced formulations, and high disease prevalence are some facto...Read More »
January : 2019The U.S. chiropractic market size was valued at USD 12.26 billion in 2017. It is projected to expand at a CAGR of 4.32% over the forecast period. The market growth largely depends on the treatment adoption from the patients who prefer non-invasive treatment of chronic pains. Increasing p...Read More »
December : 2018The global sports nutrition market size was valued at USD 11.64 billion in 2017. It is expected to register a 9.7% CAGR during the forecast period. Surging demand for various kinds of protein bars, energy drinks, and dietary supplements among bodybuilders and athletes is one of the key factors stoking the growth of ...Read More »
December : 2018The global cervical cancer treatment market size was valued at USD 6.3 billion in 2017 and is anticipated to expand at a CAGR of 5.0% during the forecast period. Increased disease prevalence, proactive government initiatives, and advent of targeted therapies are the major factors contrib...Read More »
December : 2018The global antibiotic resistance market size was valued at USD 7.81 billion in 2017. It is anticipated to register a CAGR of 5.6% from 2018 to 2025. High burden of antibiotic-resistant infections and emergence of multi-drug resistant pathogens have been augmenting the market. Pharma...Read More »
December : 2018The global plasma protein therapeutic market size was valued at USD 22.5 billion in 2017 and is anticipated to expand at a CAGR of 4.8% during the forecast period. Approval of plasma products across multiple indications, increasing R&D activities, and high demand for advanced therape...Read More »
December : 2018Global hyperhidrosis treatment market is anticipated to witness significant growth over the forecast period owing to the surge in the incidences of secondary hyperhidrosis condition globally. Rising incidences of secondary hyperhidrosis are associated with sedentary lifestyle, unhealthy ...Read More »
The global Parkinson’s disease treatment market is expected to witness significant growth over the forecast period. Increasing prevalence of Parkinson's disease is expected to accelerate the growth of this industry in near future. Additionally, combination treatments whic...Read More »
Global food allergy market is anticipated to witness noteworthy growth over the forecast period owing to an alarming rise in the number of food allergies and sensitivities around the globe. Food allergy is an abnormal response caused by food product such as tree nuts, peanut, soy. The sy...Read More »
In 2017, the global antifungal drugs market size was valued at USD 11.3 billion. Growing prevalence of fungal infections such as aspergillosis and candidiasis is one of the key factors propelling the market. Fungal infections encompass both systemic and superficial infections including i...Read More »
December : 2018The global Pompe disease market is expected to witness significant growth through the forecast period. Pompe disease (glycogenosis type II) is a rare disorder affecting approximately 1 in 40,000 people in the U.S. Factors such as continued uptake of long-term therapies, launch of novel d...Read More »
The global herbal supplements market size was valued at USD 5.26 billion in 2017 and is anticipated to grow at a CAGR of 6.2% over the forecast period. Some of the key factors contributing to the market growth are rising inclination towards natural products, awareness regarding preventiv...Read More »
November : 2018The global acute repetitive seizures market size was estimated at USD 140.5 million in 2017 and is expected to register a CAGR of 47.8% over the forecast period. High unmet clinical needs for patients, as well as caregivers, and availability of advanced product pipeline are some of the m...Read More »
November : 2018The global ADME toxicology testing market size was valued at USD 4.33 billion in 2017 and is expected to register a CAGR of 11.4% over the forecast period. A rising number of drug molecules have been failing in the final stages of clinical trials, resulting in loss of valuable time and i...Read More »
November : 2018The U.S. contraceptive market size was valued at USD 7.6 billion in 2017 and is expected to register a CAGR of 5.3% over the forecast period. Advent of newer products in the market has increased the contraceptive options, thereby augmenting the market growth over the past few years. For ...Read More »
November : 2018The global spinal muscular atrophy (SMA) treatment market size was valued at USD 883.7 million in 2017 and is anticipated to expand at a CAGR of 12.9% over the forecast period. Increasing awareness regarding Spinal Muscular Atrophy (SMA) and growing number of initiatives to improve treat...Read More »
November : 2018The global neuroendocrine tumor treatment market size was estimated at USD 1.51 billion in 2017 and is expected to register a CAGR of 10.4% during the forecast period. Increasing cases of neuroendocrine tumors (NETs) are expected to accelerate the demand for treatment options, thereby au...Read More »
November : 2018The global paroxysmal nocturnal hemoglobinuria (PNH) treatment market size was valued at USD 2.24 billion in 2017. It is expected to exhibit a CAGR of 11.2% during the forecast period. Increasing adoption of novel therapeutics, rising geriatric population, and emergence of biologics are ...Read More »
October : 2018The India large volume parenteral (LVP) market size was valued at USD 70.2 million in 2017 and is expected to exhibit a CAGR of 7.1% during the forecast period. The market is majorly driven by increased local manufacturing of LVP in the country, along with growing prevalence of chronic d...Read More »
October : 2018The global Precision Medicine (Diagnostics/Therapeutics) Market size was valued at USD 40.0 billion in 2017 and is expected to exhibit a CAGR of 9.9% over the forecast period. Diagnostic and therapeutic precision medicines are among the most complex and helpful achievements of current sc...Read More »
October : 2018The global controlled release drug delivery market size was valued at USD 31.96 billion in 2017. It is expected to witness a CAGR of 14.0% during the forecast period. Increasing acceptance of these dosage forms, ease of administration, and necessity of geriatric and pediatric dosage form...Read More »
October : 2018The global lysosomal acid lipase deficiency (LAL-D) treatment market size was valued at USD 380 million in 2017. It is expected to exhibit a CAGR of 10.8% during the forecast period. Increasing uptake of enzyme replacement therapy, continued use of supportive care therapies, and high unm...Read More »
October : 2018The global pharmaceutical cartridges market size was valued at USD 933.33 Million in 2017 and is expected to register a CAGR of 7.8% over the forecast period. Rising prevalence of chronic conditions, such as diabetes and arthritis, is expected to boost the market growth over the next few...Read More »
October : 2018The global vaginitis therapeutics market size was valued at USD 2.20 billion in 2017 and is anticipated to expand at a CAGR of 8.4% during the forecast period. Increasing awareness about women’s health, introduction of new drugs by key companies, and rising demand for improved heal...Read More »
October : 2018The global blockbuster oncology brands market size was valued at USD 28.75 billion in 2017. Heightened adoption of cancer immunotherapies in developed regions along with continual expansion of indications with accelerated approvals granting these therapies first-line treatment status is ...Read More »
October : 2018The global gaucher disease (GD) drugs market size was valued at USD 1.55 billion in 2017. It is anticipated to expand at a CAGR of 1.1% during the forecast period. Gaucher disease is an autosomal recessive metabolic disorder, with an average prevalence of 1 in 100,000 individuals. It is ...Read More »
October : 2018The global pregnancy care productsmarket size was valued at USD 22.39 million in 2017. Rising demand stemming from developing countries is one of the principal factors driving the global market towards growth. A gradual shift in trend from traditional home remedies for skincare during pr...Read More »
October : 2018The U.S. PRP and stem cell alopecia treatment market size was valued at USD 123.7 million in 2017 and is anticipated to exhibit a CAGR of 5.1% over the forecast period. Increase in number of people suffering from alopecia and rising awareness and adoption of novel treatment procedures ar...Read More »
October : 2018The Asia Pacific biopharma excipients market size was estimated at USD 473.72 million in 2017. It is projected to progress at a CAGR of 6.63% during the forecast period. High R&D investments in biosimilars coupled with patent expiration of top selling biologics is anticipated to driv...Read More »
October : 2018The artemisinin combination therapy market size was valued at USD 363.8 million in 2017. It is projected to expand at a CAGR of 8.5% during the forecast period. There has been a tremendous upsurge in the demand for artemisinin combination therapy (ACT) over the past few years following i...Read More »
October : 2018Global dry eye syndrome treatment market is estimated to increase at a significant rate over the forecast period. Increasing in the geriatric population is the major factor governing the market. According to the survey by Shire plc., it was observed that women above 50years are more like...Read More »
From ages, natural products, extracts & nature-based products have been used as a form of treatment for various acute & chronic ailments. With time, various improvements have been made to the natural products that resulted in proper dosage & properties from crude forms and no...Read More »
The global migraine drugs market size was valued at USD 1.7 billion in 2017 and is expected to exhibit a CAGR of 18.0% during the forecast period. Increased uptake of novel drug classes, launch of Calcitonin gene-related peptide (CGRP)-based therapies, and high unmet needs are some of th...Read More »
September : 2018The global sustained release excipients market size was estimated at USD 865.9 million in 2017. Rising number of patent expirations and soaring need for pediatric and geriatric dosage forms are providing a boost to the growth of the market. Growing awareness regarding added benefits prov...Read More »
September : 2018The global psoriasis drugs market size was valued at USD 11.3 billion in 2016. It is anticipated to post a CAGR of 9.4% during the forecast period. Increasing awareness regarding treatment and rising demand for improved healthcare infrastructure are among the primary growth stimulants fo...Read More »
September : 2018The global mouth ulcers treatment market size was valued at USD 937.5 million in 2017. It is expected to expand at a CAGR of 3.8% over the forecast period. Rising awareness regarding oral hygiene and increasing geriatric population is anticipated to drive the market during the forecast p...Read More »
September : 2018Around the globe, the population addicted to smoking and nicotine products have risen exponentially in the past 4 decades. Changing lifestyle, hoax beliefs such as smoking provides stress relief and nicotine abuse have been the leading factors for the population up for the usage of tobac...Read More »
The global amyloidosis treatment market size was valued at USD 3.6 billion in 2017 and is anticipated to exhibit a CAGR of 7.2% over the forecast period. Increased adoption of novel targeted therapies and transplantations, emergence of biologics, and rising geriatric population are some ...Read More »
September : 2018The global nuclear medicine market size was valued at USD 6.4 billion in 2016 and is expected to exhibit a CAGR of 10.1% over the forecast period. Need for early and accurate diagnostic methods, coupled with growing demand for better therapies, is driving the market. Increasing incidence...Read More »
August : 2018The global acne drugs market size was valued at USD 4.1 billion in 2017 and is anticipated to register a CAGR of 4.2% during the forecast period. The market is projected to exhibit moderate growth over the forecast period, which can be attributed to factors such as emergence of biologics...Read More »
August : 2018The global sickle cell disease treatment market size was valued at USD 2.1 billion in 2017 and is anticipated to exhibit a CAGR of 14.3% during the forecast period. Sickle cell disease (SCD) is a hereditary blood disorder characterized by abnormal, rigid, sickle-shaped red blood cells (R...Read More »
August : 2018The global myeloproliferative disorders drugs market size was valued at USD 7.35 billion in 2017. It is expected to register a CAGR of 3.4% during the forecast period. The U.S. dominated was at the forefront of the seven major markets.Availability of novel drugs along with presence of a ...Read More »
August : 2018The global Huntington’s disease treatment market size was valued at USD 151 million in 2017 and is expected to register a CAGR of 38.2% during the forecast period. Increased uptake of improved symptomatic therapies, promising disease-modifying therapies in the developmental pipelin...Read More »
August : 2018The global myelodysplastic syndrome (MDS) drugs market size was valued at USD 1.3 billion in 2016 and is expected to register a CAGR of 9.7% over the forecast period. The market is primarily driven by emergence of novel therapeutics. Rising geriatric population, increasing incidence of n...Read More »
August : 2018The global atopic dermatitis drugs market size was valued at USD 4.1 billion in 2016. It is expected to expand at a CAGR of 6.6% during the forecast period. Atopic dermatitis (AD) is the most common type of eczema, affecting a large percentage of world’s population. Although atopic...Read More »
August : 2018The global urothelial cancer drugs market size was valued at USD 855 million in 2017 and is expected to exhibit a CAGR of 22.9% during the forecast period. U.S. held the dominant share among the seven major markets. Market growth is largely attributed to factors such as availability of n...Read More »
August : 2018The U.S. intravenous immunoglobulin (IVIG) market size was valued at USD 3.13 billion in 2017. It is expected to register a CAGR of 6.1% during the forecast period. A rise in demand for immunoglobulin replacement therapies for the treatment of primary immunodeficiency diseases is a high ...Read More »
August : 2018The global Crohn’s disease therapeutics market size was estimated at USD 3.8 billion in 2016 and is expected to register a CAGR of 2.4% during the forecast period. Growing prevalence of the disease, along with increase in number of pipeline drugs, is expected to be a key factor dri...Read More »
August : 2018The global cholera vaccines market size was estimated at USD 63.1 million in 2017 and will exhibit a CAGR of 8.2% during the forecast period. High disease incidence rate and increasing need for its prevention are some of the key factors expected to boost the market.The WHO Global Task Fo...Read More »
August : 2018The global duchenne muscular dystrophy (DMD) drugs market size was valued at USD 365 million in 2017. It is anticipated to register a CAGR of 41.3% during the forecast period. The disease is the most common form of muscular dystrophy affecting 16 to 20 infants per 100,000 live births. DM...Read More »
August : 2018The Latin America nutrition and dietary supplements market size was valued at USD 22.01 billion in 2016. It is projected to expand at a CAGR of 8.8% over the forecast period. Increasing prevalence of chronic diseases, geriatric population, and a trend of active living are the key dr...Read More »
July : 2018The global women’s health therapeutics market size was valued at USD 108.0 billion in 2017 and is expected to expand at a CAGR of 8.8% over the forecast period. Continuous rise in prevalence of chronic and lifestyle-associated disorders in women is likely to propel market growth. I...Read More »
July : 2018The global biosimilars market size was valued at USD 4.36 billion in 2016. It is anticipated to exhibit a CAGR of 34.2% during the forecast period. Cost-effectiveness of biosimilar drugs and high prevalence of chronic disorders globally are some major factors contributing to market growt...Read More »
July : 2018The global sarcoma drugs market size was valued at $703 million in 2017. It is expected to register a CAGR of 8.5% during the forecast period. Soaring adoption of novel drugs, presence of strong developmental pipeline, rising incidence of soft tissue sarcomas (STS), and increasing R&...Read More »
July : 2018The global hyperlipidemia drugs market size was valued at USD 19.3 billion in 2016. It is estimated to progress at a CAGR of 2.3% over the forecast period. Introduction of new guidelines that redefined at-risk patient groups and emergence of novel drug classes promising better efficacy a...Read More »
July : 2018The global systemic lupus erythematosus market size was estimated at USD 1.87 billion in 2017. It is anticipated to register a CAGR of 7.0% over the forecast period. The market is estimated to gain traction with arrival of key pipeline agents, which promise higher efficacy than existent ...Read More »
July : 2018The South East Asia nutraceutical excipients market size was estimated at USD 547.28 million in 2017. Recent advances in bioactive food components and functional foods used as nutrition supplements is anticipated to drive demand. The South East Asian (SEA) market is diversified in nature...Read More »
June : 2018The global drug discovery outsourcing market size was estimated at USD 2.19 billion in 2016. Drug discovery is a long, costly, and arduous process that requires dedicated manpower, financial resources, and infrastructure. The pharmaceutical industry has witnessed radical changes in the p...Read More »
June : 2018The global kidney cancer drugs market size was valued at USD 4.4 billion in 2016 and is expected to exhibit a CAGR of 5.4% during the forecast period. U.S. dominated the scene among the seven major markets.Market growth is largely driven by factors such as availability of novel drugs, pr...Read More »
June : 2018The global colorectal cancer drugs market size was valued at USD 8.6 billion in 2016, exhibiting a CAGR of 3.3% during the forecast period. Colorectal cancer (CRC) accounted for approximately 8.0% of the global cancer incidence in 2016, making it the third most common cancer type, follow...Read More »
June : 2018The global liver cancer drugs market size was valued at USD 424 million in 2016. It is expected to progress at a CAGR of 19.4% during the forecast period. The U.S. spearheaded the market among seven major countries.Availability of novel drugs, presence of strong pipeline, and rising publ...Read More »
June : 2018The global tuberculosis drugs/therapeutics market size was estimated at USD 915.6 million in 2016 and is anticipated to exhibit a CAGR of 5.2% over the forecast period. High incidence of drug susceptible (DS) tuberculosis (TB), rise in multi-drug resistant (MDR) TB cases, and increase in...Read More »
May : 2018The global ovarian cancer drugs market size was valued at USD 1,030 million in 2016. It is expected to exhibit a phenomenal CAGR of 23.7% during the forecast period, with the U.S. at the forefront of the growth. Rising incidence of ovarian cancer, owing to growing geriatric population an...Read More »
May : 2018The Europe nutrition and supplements market size was valued at USD 31.7 billion in 2016 and is anticipated to register a CAGR of 5.9% over the forecast period. Availability of a large number of commercialized products coupled with presence of a wide base of target consumers is one of the...Read More »
May : 2018The global hepatitis therapeutics market size was estimated at USD 19.6 billion in 2016, and is anticipated to grow at a CAGR of 2.7% during the forecast period. Few prominent factors that are expected to boost the market are growing prevalence of viral hepatitis, rise in the number of a...Read More »
April : 2018The global head and neck cancer drugs/therapeutics market size was valued at USD 752.5 million in 2016 and is projected to expand at a CAGR of 9.4% during the forecast period. The current standard of care for head and neck cancer includes surgery, radiation therapy, chemotherapy, and imm...Read More »
March : 2018The global thalassemia market size was valued at USD 1.72 billion in 2016 and is estimated to expand at a CAGR of 10.8% during the forecast period. Large population, increase in awareness about available treatment options, and rise in demand for improved curative gene therapies are some ...Read More »
March : 2018The global thyroid gland disorder treatment market size was valued at USD 1.97 billion in 2016 and is expected to register a CAGR of 3.2% during the forecast period. Rising incidence of hypothyroidism and growing awareness levels among individuals are key contributors to market growth. V...Read More »
March : 2018The global gastrointestinal therapeutics market size was valued at USD 51.9 billion in 2016 and is slated to expand at a lucrative CAGR of 6.6% over the forecast period. Increasing adoption of biologics for treatment of gastrointestinal diseases is the primary driver of the market. Accor...Read More »
March : 2018The global intravenous immunoglobulin (IVIG) market size was estimated at USD 9.09 billion in 2016 and is anticipated to grow at a CAGR of 7.1% over the forecast period. Growing geriatric population, rising prevalence of immunodeficiency diseases, increasing adoption of IVIG treatments a...Read More »
February : 2018The global vaccine contract manufacturing market size was valued at USD 1.8 billion in 2016 and is projected to expand at a CAGR of 9.3% during the forecast period. At present, apart from safety and effectiveness of inoculations, the number of products developed per year is also an impor...Read More »
February : 2018The local anesthesia drugs market size was valued at USD 4.65 billion in 2016 and is expected to expand at a CAGR of 3.7% over the forecast period. There has been an increase in number of surgical procedures performed across the globe, including dental procedures, cosmetic surgeries, and...Read More »
February : 2018The global rheumatoid arthritis drugs/therapeutics market size was valued at USD 20.3 billion in 2016. The market is anticipated to expand at a CAGR of 4.6% over the forecast period. Increasing prevalence of arthritis, growing acceptance of biopharmaceuticals, and presence of well-define...Read More »
February : 2018The global Breakthrough Therapy (BT) designation market size was valued at USD 44.1 billion in 2016 and is expected to grow at a CAGR of 14.1% during the forecast period. The BT designation is granted to drugs that bring about substantial improvement in disease conditions compared to exi...Read More »
January : 2018The global excipients market size was estimated at USD 4.1 billion in 2016. Increasing usage of generic medicines and rising demand for multifunctional excipients is expected to be key factors driving revenue growth. Excipients have been recognized to provide better functionality and com...Read More »
January : 2018The global pediatric vaccines market was estimated at USD 22.4 billion in 2016. Increase in government and non-government funding for development of novel vaccines, along with initiatives for raising awareness about immunization, is likely to have a positive impact on market growth. In a...Read More »
January : 2018The global smart pills market size was worth USD 779.4 million in 2016 and is anticipated to expand at a CAGR of 16.3% over the forecast period. High demand for minimally invasive procedures, increase in focus on patient convenience, and technological development including miniaturizatio...Read More »
December : 2017The global human growth hormone market size was valued at USD 3.7 billion in 2016 and is projected to grow at a CAGR of 7.5% over the forecast period. Investment by market players, the presence of strong pipeline, and rising affordability of hormone therapy in the emerging countries are ...Read More »
December : 2017The global pharmerging market size was valued at USD 548.3 billion in 2016 and is expected to grow at a CAGR of 17.1% over the forecast period. The increasing geriatric population, increasing healthcare expenditure, increasing the number of private hospitals, and increasing disease burde...Read More »
December : 2017The global angina pectoris drugs market size was valued at USD 8.5 Billion in 2016 and is expected to grow at a CAGR of 3.2% during the forecast period. The U.S. dominated angina pectoris drugs market among the seven major countries. The global angina pectoris market is expected to be co...Read More »
November : 2017The global bipolar disorder market size was valued at USD 4.9 billion in 2016 and is expected to grow at a CAGR of 2.1% during the forecast period. Increasing prevalence of bipolar disorder, government support for generating awareness about the bipolar disorder, and technological advance...Read More »
November : 2017The global preclinical CRO market size was valued at USD 3.25 billion in 2016 and is expected to grow at a CAGR of 8.3% during the forecast period. Increase in focus of life science companies on their core competencies coupled with rise in outsourcing of noncore functions is further expe...Read More »
November : 2017The global schizophrenia drugs market size was valued at USD 6.8 billion in 2016 and is estimated to grow at a CAGR of 2.5% over the forecast period. Schizophrenia, a chronic disorder of the central nervous system, affects 1.0% of the global population or seven out of 1,000 individuals. ...Read More »
November : 2017The U.S. specialty injectable generics market size was valued at USD 8.05 billion in 2016 and is expected to witness a lucrative CAGR of 14.9% over the forecast period. Increase in prevalence of target diseases, such as cancer, hepatitis C, multiple sclerosis, and others, has resulted in...Read More »
November : 2017The global insomnia therapeutics market size was valued at USD 2.18 billion in 2016 and is expected to grow at a CAGR of 5.3% over the forecast period. Increasing prevalence of insomnia across the world, rising stress level, growing geriatric population, and increasing awareness about va...Read More »
October : 2017The global polycystic ovarian syndrome treatment market size was valued at USD 3.3 billion in 2016 and is expected to grow at a CAGR of 5.0% over the forecast period. According to the research conducted by American Academy of Family Physicians, approximately 7% women of reproductive age ...Read More »
October : 2017The global acute lymphocytic/lymphoblastic leukemia therapeutics market size was valued at USD 1.5 billion in 2016 and is expected to grow at a CAGR of 10.0%. Rise in incidence of Acute Lymphoblastic Leukemia (ALL) and increase in initiatives undertaken by public and private organization...Read More »
October : 2017The global vaccine adjuvants market size was valued at USD 308.99 million in 2016 and is anticipated to grow with a CAGR of 10.6%. Rising prevalence of cervical cancer, infectious diseases such as Human Papillomavirus (HPV), HIV, tuberculosis, etc., and other fatal diseases is expected t...Read More »
September : 2017The global xerostomia therapeutics market size was estimated at USD 602.3 million in 2016. Increasing adoption of chemotherapy and radiotherapy in cancer treatment coupled with rising use of prescribed medications are some of the key factors expected to boost the xerostomia therapeutics ...Read More »
September : 2017The global specialty generics market size was estimated at USD 30.0 billion in 2016. Rise in prevalence of chronic diseases, such as cancer, multiple sclerosis, hepatitis C, and others, has led to high demand for specialty generic drugs. According to American Cancer Society, in the U.S.,...Read More »
September : 2017The global medical flexible packaging market size was valued at USD 20.14 billion in 2016 and is expected to witness rapid growth owing to the rising demand from the pharmaceuticals and medical device manufacturing industries. Flexible packaging provides various advantages such as low wa...Read More »
August : 2017The global infectious disease therapeutics market size was valued at USD 46.88 billion in 2016 and is projected to grow at a CAGR of 6.6% during the forecast period. Rising prevalence of infectious ailments, increasing expenditure to boost the penetration rate of treatments of these dise...Read More »
August : 2017The global narcolepsy therapeutics market size was estimated at USD 1,305.2 million in the year 2016. The market is expected to grow substantially owing to the rising incidence across the globe. Narcolepsy is generally a lifelong sleep disorder with occurrence of sudden uncontrollable sl...Read More »
August : 2017The global melanoma therapeutics market size was valued at USD 4.2 billion in 2016 and is anticipated to witness CAGR of 11.21% during the forecast period. Rising incidence of melanoma and other skin cancers is expected to accelerate demand for anticancer agents. According to WHO, about ...Read More »
August : 2017The global superdisintegrants market size was valued at around USD 258.6 million in 2016 and is expected to grow at a CAGR of 7.2% over the forecast period. Factors such as growing generic drugs market, geriatric and pediatric population who have difficulty in swallowing tablet/capsules ...Read More »
August : 2017The global Central Nervous System (CNS) therapeutic market size was worth USD 77.2 billion in 2016 and is anticipated to grow at a CAGR of 5.9% during the forecast period. Advancements in diagnostics, therapeutics, and drug discovery techniques are primarily driving the growth of the mar...Read More »
July : 2017The global clinical trial supplies market size was valued at USD 1.7 billion in 2016 and is expected to grow at a CAGR of 7.3% over the forecast period. Globalization and rise in number of clinical trials, increasing complexities and rising number of biologics and biosimilar drugs in tri...Read More »
July : 2017The global astaxanthin market size was estimated at USD 555.4 million in 2016. High demand due to its antioxidant properties and increasing applications in the aquaculture industry are key factors affirming growth of this market. Furthermore, a rise in health-conscious population and gro...Read More »
July : 2017The global high potency active pharmaceutical ingredients (APIs) market was valued at USD 14.4 billion in 2016 and is expected to grow at a CAGR of 10.3% over the forecast period. Highly potent APIs are capable of targeting diseased cell selectively and more precisely than other compound...Read More »
July : 2017The global peptide therapeutics market was valued at USD 21.5 billion in 2016 and is expected to grow at CAGR of 9.4% over the forecast period.Increasing prevalence of cancer and metabolic disorders such as osteoporosis, obesity, & diabetes are the key factors contributing toward the...Read More »
July : 2017The global pneumonia therapeutics market size was estimated at USD 11.9 billion in 2016 and is anticipated to grow at a CAGR of 8.0% throughout the forecast period. Increasing incidence of pneumococcal disease is a high impact rendering driver. Over the years, there has been a significan...Read More »
July : 2017The global aptamers market size was valued at USD 723.6 million in 2016 and is projected to grow at a CAGR of 28.2% during the forecast period. Nowadays, this small multifunctional molecule is a widely studied biomedical class amongst scientists across the globe owing to various advantag...Read More »
June : 2017The global cystic fibrosis therapeutics market size was estimated at USD 3.56 billion in 2016. Increasing prevalence of Cystic Fibrosis (CF) coupled with rising treatment rate is one of the key factors anticipated to propel the demand for these therapeutics over the forecast period. More...Read More »
June : 2017The global erythropoietin (EPO) drugs market size was valued at USD 7.4 billion in 2016 and is expected to witness CAGR of 11.5% during the forecast period. Increasing incidence of chronic diseases such as end-stage renal diseases, cancer, and HIV is expected to accelerate demand for EPO...Read More »
May : 2017The global oncology based in-vivo CRO market size was valued at USD 725.0 million in 2016 and is expected to grow at a CAGR of over 8.0% over the forecast period. Immunodeficient mice based models are commonly utilized to conduct oncology research across the globe. Factors responsible fo...Read More »
May : 2017The global radiodermatitis market size was estimated at USD 310.9 million in 2016 and is anticipated to grow at a CAGR of 4.0% throughout the forecast period. The market is predominantly driven by growing number of patients suffering from radiodermatitis as an adverse effect of radiation...Read More »
May : 2017The global prostate cancer therapeutics market size was valued at USD 7.9 billion in 2016 and is expected to grow at a CAGR of 4.8% over the forecast period. As per data published by the World Cancer Research Fund International, more than 1.1 million cases of prostate cancer were reporte...Read More »
May : 2017The global pharmaceutical contract manufacturing & contract research market size was valued at over USD 123.1 billion in 2016. Cost saving and time saving benefits associated with the implementation of outsourcing is responsible for driving the industrial growth. Companies are invest...Read More »
May : 2017The Middle East and Africa parenteral nutrition market size was valued at USD 203.6 million in 2016 and is expected to grow at a CAGR of 7.1% over the forecast period. Increasing natality rate, rising number of premature births, risk of malnutrition, and increasing prevalence of chronic ...Read More »
May : 2017The global protein expression market size was estimated at USD 1.2 billion in 2016. Growing demand for novel biologic product for the treatment of severe chronic diseases such as cancer, anemia, and multiple sclerosis is a major factor contributing toward the growth of the market. Protei...Read More »
May : 2017The global nanomedicine market size was estimated at USD 138.8 billion in 2016. Technological advancements coupled with relevant applications in early disease diagnosis, preventive intervention, and prophylaxis of chronic as well as acute disorders is expected to bolster growth in this m...Read More »
April : 2017The global nanoparticles - metal & metal oxides market in healthcare was estimated at USD 25.86 billion in 2016. Presence of a substantial number of metal nanoparticle based medicines that are currently approved by the U.S. FDA is one of the key factors for estimated revenue. In addi...Read More »
April : 2017Global gout therapeutics market is expected to gain a profitable progress over the forecast period owing to the factors such as the development of newer therapies which can be used as the add-on therapies with the already available treatment for gout....Read More »
March : 2017The global rat model market size was valued at USD 412.3 million in 2016 and is expected to grow at a CAGR of 8.3% over the forecast period. Growing development of new medical devices and biotechnological products is anticipated to support growth of the market. Rising number of new playe...Read More »
March : 2017The global Non-small Cell Lung Cancer (NSCLC) therapeutics market size was valued at USD 6.2 billion in 2016 and is projected to grow with CAGR of 7.5% over the forecast period. This high growth is attributed to the increasing patient population, expected entry of several drugs, and risi...Read More »
March : 2017The global biologics market size was valued at USD 276.6 billion in 2015. These products represent cutting-edge research and also enable latest scientific discoveries. Such discoveries can be translated into novel therapies that provide new treatment options for patients. Moreover, incre...Read More »
March : 2017The global antipsychotic drugs market size was valued at USD 11.7 billion in 2015 and is expected to grow at a CAGR of 2.1% over the forecast period. Growing prevalence of psychosis and related diseases is driving the demand for antipsychotic drugs. The major factors contributing towards...Read More »
February : 2017The global Gastroesophageal Reflux Disease (GERD) therapeutics market size was valued at USD 5.66 billion in 2016 and is expected to witness a decline in its revenue to USD 4.34 billion by 2025, shrinking at a CAGR of 2.9%. Patent expiry of blockbuster drugs prescribed for the treatment ...Read More »
February : 2017The global pancreatic cancer treatment market size was valued at USD 1.7 billion in 2015. The rising prevalence of obesity, alcohol consumption, and smoking is expected to propel the market growth. In addition, growing geriatric population is expected drive the growth of the pancreatic c...Read More »
February : 2017The global antiviral drugs market size was valued at USD 41.1 billion in the year 2015 and is estimated to reach a value of USD 69.2 billion by 2025, growing at a CAGR of 4.0%. The growing prevalence of Sexually Transmitted Infections (STIs) coupled with presence of strong product pipeli...Read More »
February : 2017The global osteoporosis drugs market size was accounted for USD 11.5 billion in 2015 and is expected to grow at a CAGR of 3.3% over the forecast period. The market is largely driven by a significant rise in the prevalence of this disorder globally. This unprecedented rise in the prevalen...Read More »
January : 2017The global medical marijuana market size was valued at USD 11.4 billion in 2015 and is projected to grow with CAGR of 17.1% during the forecast period. The market is experiencing growth due to rising awareness regarding various medical applications such as pain management, appetite enhan...Read More »
January : 2017The global nanocapsules market size was valued at USD 1.9 billion in 2015 and is expected to witness attractive CAGR of 7.9% over the forecast period. Nanocapsules are vesicular systems composed of polymer membrane encompassing an inner core of the desired substance at the nanoscale. Thi...Read More »
January : 2017The global botulinum toxin (BNT) market was valued at USD 3.4 billion in 2015 and is expected to grow at a CAGR of 7.9% over the forecast period. Growing population aged between 25 to 65 years and increasing demand for minimally invasive or non-invasive procedures are the prime factors f...Read More »
January : 2017Latin America pharmaceutical contract manufacturing & research services market was valued at over USD 11.4 billion in 2015. Drug shortfall, rising competition, tighter budgets, insufficient resources, and patent expiration are some of the key factors boosting growth in the market ove...Read More »
January : 2017The global pharmaceutical/biotechnology services outsourcing market was valued at USD 40.3 billion in 2015 and is expected to grow at a CAGR of 8.7% over the forecast period. Increasing competition within the healthcare drug manufacturers is one of the prime factor responsible for the gr...Read More »
December : 2016The Culturing or farming of aquatic animals like fishes, crustaceans, mollusks, algae, aquatic plants, and the other aquatic organisms in different types of water is termed as “Aquaculture”. The cultivation process involves nurturing of these aquatic organisms in the controll...Read More »
Anemia is a condition wherein there is a decrease in the total amount of red blood cells or haemoglobin in the blood. Haemoglobin is an essential part of the red blood cells and binds oxygen. In case of low or abnormal red blood cells the cells in the body will not receive appropriate am...Read More »
An antithrombotic agent is a drug that reduces the formation of blood clots. Antithrombotics could be used therapeutically for prevention (primary prevention, secondary prevention) or treatment of a dangerous blood clot (Acute thrombus). Antithrombotic is a drug that helps reduce thrombu...Read More »
Osteoporosis disease is the most prevalent disease that occurs due to bone mineral density which causes heavy risk of fractures and bone fragility. The disease occurs mostly in spine, hip, shoulder and forearm.Hip fractures are most common as nearly one-third of patients lose mobility an...Read More »
Avian influenza (AI), can be commonly known as bird flu. It is an infectious viral disease of birds. It is generally found in ducks and geese which live in open rivers. Avian influenza virus can cause infection in poultry and livestock which may result into an endemic. Avian influenza is...Read More »
Biohazard waste, better known as biomedical waste that include wastes from hospitals or laboratory origin along with wastes from research laboratory containing biomolecules or wastes that are hazardous to environmental conditions. Biomedical waste can be in solid or liquid form, namely u...Read More »
Branded drugs are patented drugs. When a pharmaceutical company discovers a new drug, it files for a patent. Branded generics are generic versions of products sold either by the original manufacturer of the patented drug or by generic manufacturers that build up brand equity for their ge...Read More »
Bronchitis is a respiratory disease in which there is inflammation of the bronchi in the lungs. In other words, bronchitis is an inflammation of the lining of bronchial tubes that carry air to and from the lungs. Some of the common signs and symptoms of bronchitis include cough, fatigue,...Read More »
The global drug and gene delivery system market size was valued at USD 379.2 Billion in 2015. Growing efforts towards formulating dosage forms that would help in maximizing the bioavailability of the drug at target site while increasing the patient convenience are driving the global mark...Read More »
December : 2016The Anticonvulsants are the diverse group of the pharmacological agents used in the treatment of epileptic seizures. Anticonvulsants are also increasingly being used in the treatment of bipolar disorder and borderline personality disorder. They seem to act as mood stabilizers, and for th...Read More »
The global microbiome therapeutics market size was valued at USD 11.3 million in 2015. Increasing prevalence of diseases due to dysbiosis of microbiota in the gut and provisioning of a high amount of funding for biological drug development studies are the key drivers affirming growth of ...Read More »
December : 2016The global immunomodulators market accounted for USD 131.7 billion in 2015 and is expected to grow at a CAGR of over 5.8% during the forecast period. The increasing incidence of chronic diseases including asthma, cancer, allergic conditions, and multiple sclerosis is presumed to be the k...Read More »
December : 2016The global multiple myeloma therapeutics market was valued at USD 7.5 billion in 2015 and is projected to grow at a CAGR of 16.6% over the forecast period. The high growth is anticipated on account of the approval attained for the newer drugs in the market. In addition, limited efficienc...Read More »
November : 2016The global doxorubicin market size was valued at USD 809.6 million in 2015 and is projected to grow at a CAGR of 6.4% over the forecast period. Increasing government intervention to support technological advancement in clinical oncology such as intravenous freetherapy and digital mi...Read More »
November : 2016The global genitourinary drugs market accounted for USD 28.2 billion in 2015 and is anticipated to grow at a CAGR of over 0.8% during the forecast period. The growing prevalence of genitourinary disorders is presumed to be the high rendering impact driver of this vertical. In addition, i...Read More »
November : 2016The APAC Radiopharmaceuticals market was valued at USD 1.1 billion in 2015 and is expected to witness a CAGR of 10.9% over the forecast period. Radiopharmaceuticals are being extensively used for molecular imaging, which involves the use of these molecules as biomarkers for specific mole...Read More »
October : 2016The global Human Immunodeficiency Virus (HIV)-1 therapeutics market was valued at USD 13.5 billion in the year 2015 and is estimated togrow at a CAGR of 1.4% from 2016 to 2025. The market growth can be linked to the surging incidence rate of HIV-1 infection, which unlike the death rate f...Read More »
October : 2016The global biological implants market was valued at USD 5,070.8 million in 2015 and is expected to exhibit a growth rate of 7.6% over the forecast period. With technological breakthroughs in the fields of regenerative medicine and tissue engineering, the market for biological implants is...Read More »
October : 2016Global human rabies vaccines market is expected to witness robust growth over the forecast period. Increasing global incidences of mortality due to rabies, growing issue of stray dogs in countries with low economic development, rising number of pets, lack of pet management services, low ...Read More »
The global market for anti-tumor drugs is expected to surpass USD 110 billion by 2022, growing at a CAGR greater than 6% over the forecast period. The market growth may be attributed to increasing demand and continuous development in the field of medicine. However, high cost and the side...Read More »
ACS or Acute Coronary Syndrome refers to the set of conditions which occurs on account of decreasing flow of blood in coronary arteries owing to which the heart muscle is not able to function. There are various symptoms associated with this condition. The most commonly occurring symptom ...Read More »
Global anti-obesity therapeutics market is forecasted to grow at a CAGR of above 20.0%. On account of increasing prevalence of obesity worldwide. Incidences of obesity are increasing fiercely over the past decades and is often described as a global endemic, particularly in the developed ...Read More »
The Arthroscopy market was valued at USD 4.0 billion in 2015 and is expected to witness a CAGR of 4.9% over the forecast period. Rising geriatric population is primarily driving the growth of the as this population bracket is most prone to injuries requiring arthroscopic procedures. ...Read More »
August : 2016The North America Opioid Market was valued at USD 12.4 billion in 2015 and is expected to witness growth at a CAGR of 4.6% over the forecast period....Read More »
August : 2016The global Alzheimer’s therapeutics market was valued at USD 4.0 billion in 2015 owing to the increasing prevalence and incidence rates of this disease and growing geriatric population base. In 2015, it was estimated that 47 million people were living with Alzheimer’s Disease...Read More »
August : 2016The global Vaccine Market was valued at over USD 32.5 billion in 2015 and is expected to grow at a CAGR of 10.3% over the forecast period. The rising demand for better healthcare infrastructure and high awareness levels of the benefits of immunization are the major factors boosting the m...Read More »
August : 2016The Fondaparinux market was valued at USD 365.9 million in 2015 and is expected to witness a CAGR of 7.8% over the forecast period. The increasing base of health conscious population coupled with presence of generic alternatives is estimated to boost market growth....Read More »
July : 2016The global epilepsy drugs market was valued at USD 4,100 million in 2015. The expected launch of drugs currently in the pipeline, such as Ganaxolone by Marinus Pharmaceuticals, Inc., Perampanel by Eisai Co., Ltd., USL261 by Upsher Smith Laboratories, Inc., and YKP3089 by SK Life Sciences...Read More »
July : 2016The global empty capsules market was valued at USD 1.34 billion in 2015. Key factors responsible for the growth include the increasing geriatric population, the high demand of empty capsules in the pharmaceutical, nutraceutical, and cosmeceutical industries, and the growing consumer pref...Read More »
July : 2016The global asthma therapeutics market accounted for USD 20.7 billion as of 2015 and is anticipated to exhibit a sluggish growth rate of 2.2% over the forecast period. This is attributed to the generic erosion faced by leading brands, such as Advair and Symbicort....Read More »
July : 2016Global liver diseases therapeutics market size was valued at USD 7,498.2 million in 2014. Key drivers of the market include increasing incidences of hepatocellular carcinoma and other liver diseases along with huge untapped needs of patients suffering from such diseases....Read More »
July : 2016Global erectile dysfunction drugs market size was valued at over USD 4.39 billion in 2014. Key drivers of the market include increase in patient awareness and education levels and growing base of geriatric population. ...Read More »
July : 2016The global contraceptives market is estimated to grow at a lucrative rate over the forecast period owing to, increasing prevalence of sexually transmitted diseases and growing need for population control. Moreover, the implementation of initiatives aimed at curbing unwanted pregnancies associated healthcare expendit...Read More »
June : 2016Growing awareness related to smoking cessation therapy and smoking health hazards amongst the population are major drivers for the smoking cessation and nicotine de-addiction product market....Read More »
June : 2016The global geriatric medicine market was valued at nearly USD 540 billion in 2015. One of the key factors attributing to its rapid growth include rapidly increasing geriatric population base....Read More »
June : 2016Stomach cancer is a type of cancer that begins when the cancer cells form in the inner lining of the stomach. Stomach cancer is also known as gastric cancer. Gastric cancer usually progresses slowly. Some of the early symptoms include indigestion, heartburn, slight nausea, loss of appeti...Read More »
The global multiple sclerosis therapeutics market size was valued at USD 20.01 billion in 2015. The rising base of the target population suffering from relapsing-remitting and secondary progressive multiple sclerosis coupled with the increasing demand for novel potent drugs is a key fact...Read More »
May : 2016The global aminoglycosides market size was valued to be over USD 1.1 billion in 2014 and is expected to witness a growth of over 3.0% CAGR in the coming years owing to rising incidence of bacterial infections caused by gram-positive and gram-negative bacteria. Usage of these drugs in the...Read More »
April : 2016Viral Conjunctivitis also known as “pinkeye”. It is a highly contagious acute conjunctival infection usually caused by adenovirus. Some of the other viruses that can cause conjunctival infection consist of herpes simplex virus (HSV), varicella-zoster virus (VZV), picornavirus...Read More »
Viruses are microscopic organisms which are contagious agents that reproduce only inside the living cells of other organism. Viruses can infect all types of life forms right from a bacterium to archaea and also animals and plants to microorganisms. Viruses are not alive. They do not have...Read More »
Vitamin tonics are known for their ability to strengthen and invigorate the body tone of a human being. They are being utilized for the prevention and treatment of various deficiency conditions including rickets, osteomalacia, angular stomatitis, and anemia. They are available in differe...Read More »
Every year, millions of people drive to ski slopes, skating rinks and frozen ponds to enjoy a few hours of skating, sledding, skiing, ice hockey, and the other winter sports. Along with those great times, though, come common winter sports injuries could be prohibited with the right safet...Read More »
Zoonotic Disease is any disease spread from animals to people. Here are several well-known zoonotic diseases. Many of them are very much aware known like Lyme disease and malaria. Relatively less known zoonotic sicknesses comprise alveolar hydatid disease [echinococcosis], ancylostoma in...Read More »
The global hormone replacement therapy market size was valued at USD 15.1 billion in 2014 and is expected to grow at a CAGR of 8.2% over the next seven years. ...Read More »
March : 2016The global liposomal doxorubicin market size was valued at USD 814.6 million in 2015 and is projected to grow at a CAGR of 6.2% during the forecast period. The market is experiencing growth due to rising breast & ovarian cancer cases and growing awareness regarding the bene...Read More »
January : 2016The global anxiety disorders and depression treatment market size was valued at USD 15.2 billion in 2015 and is anticipated to show steady growth due to the increasing prevalence of anxiety disorder and depression worldwide. According to estimates published by the World Health Organizati...Read More »
December : 2015Growing prevalence of conditions associated with pruritus such as atopic dermatitis, urticaria, and psoriasis is expected to serve the market as high impact rendering drivers. Moreover, presence of high unmet medical needs and the subsequent introduction of new products such as REMITECH ...Read More »
March : 2015The global antidiabetics market was valued at USD 41,609.7 million in 2013 and is expected to grow at a CAGR of over 10.0% during the forecast period. Growing worldwide prevalence of diabetes (both type I and type II) is expected to be a key driver for insulin and oral hypoglycemic drugs...Read More »
January : 2015ITP (immune thrombocytopenic purpura) is recognized as an rare disease owing to its low prevalence rates. As per the U.S. FDA the disease has an incidence rate of 3.3 cases per 100,000 in the country. Moreover, according to the European Medicines Agency (EMEA), in Europe, incidence rate ...Read More »
December : 2014Biotechnology reagents are used in research fields of genetics, molecular biology, diagnosis, immunology, bioscience and in education. Biotechnology reagent market depends on the growth of biotechnology instrumentation market. Increasing research and development expenditure by biotechnol...Read More »
Artemisinin market is expected to witness substantial growth over the forecast period owing to its increasing application scope in pharmaceutical industry. ...Read More »
Biopharmaceuticals are drugs used for medical purposes and are produced by the extraction of proteins and nucleic acids direct from the biological source using biotechnology. Most of the biopharmaceuticals are the pharmaceutical products derived from the life forms, genetically modified ...Read More »
The global pharmaceutical manufacturing market is expected to witness lucrative growth over the forecast period, owning to the increasing prevalence of chronic diseases and the growing demand for medications. Major drivers for the market are improved healthcare standards, quick and immed...Read More »
Lung cancer is differentiated in to two types as non small cell lung cancer (NSCLC) and small cell lung cancer (SCLC). Lung cancer is the uncontrolled growth of cells in the lung tissues. Majority of the lung cancer are NSCLC....Read More »
Increasing prevalence of chronic diseases, growing R&D activities, rising awareness pertaining to minimally invasive surgical procedures and development of technologically advanced medical devices which are compact, precise and efficient are amongst key factors for the growth of nano...Read More »
Medical imaging reagents are compounds designed to improve the image created through imaging devices. Reagents allow doctors to analyse whether a tumour is benign or malignant and facilitates to trace any cancerous spot in the body. The improvement of medical imaging reagent includes syn...Read More »
Introduction of advanced technologies such as novel intelligent inhalers and micro-needle transdermal patches is one of the high impacts rendering driver for top 10 drug delivery technologies market....Read More »
The increasing morbidity rates of Nosocomial infection worldwide along with the prevalence of pathogens, bacterial, fungal & viral diseases are the vital drivers for the growth of hospital acquired infection or hospital associated infection (HAI) diagnostics market. Another important...Read More »
Rising prevalence of cardiovascular disorders, increasing geriatric population base coupled and growing need for repeat revascularization procedure are the major growth propellers of coronary artery bypass graft devices (CABG) market. ...Read More »
Cancer is a disease caused by uncontrolled and abnormal cell proliferation which invade or spread to other body parts and is known as malignant tumor. As per the WHO, cancer which includes breast cancer, cervical cancer, liver, stomach, prostate cancer and others is one of the well-known...Read More »
Anti-inflammatory peptides market is expected to grow over the forecast period owing to the increasing incidences of diseases such as autoimmune diseases, inflammatory bowel disease, multiple sclerosis, and psoriasis. As per the report published by the World Psoriasis Day in 2013, says t...Read More »
D-dimer is a protein fragment which has two cross linked D fragment of protein called fibrin. It is a fibrin degradation product (FDP) which is found in human blood sample after the blood clot is degraded by fibrinolysis. They are present in blood plasma only when blood coagulation syste...Read More »
Insulin is one of the most important hormones secreted in human body. Insulin opens the door for glucose to enter into blood cells. Insufficient production of insulin by human body leads to stockpiling of sugar in blood cells which causes diabetes. ...Read More »
July : 2014Atrial fibrillation (AF) is a type of cardiac arrhythmia which is caused by irregular electrical activities in the atria. It may occur with no symptoms but most common ones associated with it are fainting, palpitations, congestive failure of the heart or chest pain. The confirmation for ...Read More »
July : 2014Lifestyle drugs market is luring various pharmaceutical companies globally and is anticipated to grow substantially over the forecast period. Key driver for the lifestyle drugs market is increasing usability of these drugs by all age groups, rising demand to enhance life expectancy and r...Read More »
Insulin is a body hormone and is an internal secretion of the pancreas formed by a group of cells referred to as the islets of Langerhans. The primary functions of this hormone are to enable the entry of glucose into the cells and provide energy and to help maintain blood glucose levels ...Read More »
June : 2014Dilated cardiomyopathy (DCM) is a cardiac disorder caused by enlargement of heart. The muscular walls of the heart become weak due to enlargement and hence heart is not able to pump blood efficiently. The disorder causes effect on liver, lungs and other important organs of the body stead...Read More »
BELVIQ, a product of Arena Pharmaceuticals GmbH. is an FDA-approved prescription weight-loss medication that helps overweight and obese adults lose weight and keep it off. ...Read More »
Tissue sealants market is expected to grow over the forecast period owing to the increasing surgical procedure. Increase in the number of surgical interventions as a consequence of rising incidences of trauma conditions due to the rise in number of sports injuries, and increasing number ...Read More »
Cholangitis is the term used for infection in the common bile duct of the individual. Bile duct is the tube that carries bile juice, which is helpful for digestion, from liver to intestine and gallbladder....Read More »
Rising prevalence of autoimmune diseases is the major driver attributing towards the growth of the autoimmune treatment market. ...Read More »
The global wound care sealants market is expected to experience a lucrative growth on account of increasing number of surgeries all over the world. Advancement in wound care products which include hydrocolloids, fibrin, collagen, hydrogels, rising awareness among the population about the...Read More »
Insulin is a hormone which facilitates the entry of glucose into the blood cells. The body’s inability to produce appropriate amount of insulin leads to accumulation of sugar in the blood stream leading to a rise in blood sugar levels and eventually diabetes. ...Read More »
May : 2014Genetic analysis refers to study of DNA and RNA or the basic structure of genes for varied analytical purposes. Genetic analysis has emerged as an important tool in the fields of diagnostics, drug discovery, and biomedical research. It is helpful in determining occurrence of diseases and...Read More »
Any organization which provides support to the medical device industries, pharmaceutical firms etc. in the form of outsourced research services on a contractual basis are said to be contract research organizations (CRO)....Read More »
Increasing prevalence of genetic diseases such as Down syndrome, Edward syndrome and Patau syndrome in new born and prenatal is the high impact rendering driver for the growth of prenatal & newborn genetic testing market. Increasing demand for prenatal & newborn ge...Read More »
Increasing prevalence of scleroderma and rising incidences of genetic mutations coupled with drastic changes in environment is the high impact rendering divers for scleroderma diagnostics and therapeutics market....Read More »
Global biotechnology instrumentation market is anticipated to witness lucrative growth over the forecast period. Key driver of the market is the rising need of biotechnological tools in biotech, pharmaceutical and other related industries. Pharmaceutical companies are expected to improve...Read More »
Global neurometabolic disorders market is expected to grow at lucrative rate during the forecast period owing to the increasing incidence of various neurometabolic disorders. The growing demand of rapid diagnostic techniques over current techniques due to factors such as long turnaround ...Read More »
The global gene amplification technologies market is expected to grow over the forecast period due to the growing need for genetic information for the purpose of identifying and mapping all the genes of human genome. Key drivers for the growth of gene amplification technology industry&nb...Read More »
Global dyslipidemia drugs market is expected to witness lucrative growth over the forecast period owing to growing prevalence of lipid associated disorders and cholesterol abnormalities. These include triglyceride abnormalities and inability of the body to metabolize fats and biomolecula...Read More »
Deceptive representation of an original pharmaceutical and food product is referred to as counterfeiting. High growth of cheap and low quality counterfeit products especially pertaining to the pharmaceutical and food industries have accelerated the rate of implementation of anti-counterf...Read More »
Leukemia therapeutics market is expected to witness high growth during forecast period due to rising incidences of chronic diseases worldwide. Leukemia is identified by the spread of disease (acute and chronic) commonly caused due to exposure to radiations, unhealthy lifestyle habits and...Read More »
The global acute myeloid leukemia therapeutics market is anticipated to gain lucrative growth over the forecast period as a consequence of rising incidences of acute myeloid leukemia and its relapse cases across the globe. Increasing need of advanced therapeutics is also a high-impact re...Read More »
Contraception is more commonly known as fertility and birth control which are described as the methods to avoid pregnancy. These devices and drugs function by changing the mechanism of ovulation or by acting as a physical barrier between the sperm and ovum....Read More »
January : 2014Global schizoaffective disorders treatment market is expected to experience an upsurge due to rising torpid lifestyle, increasing healthcare spending and awareness, prevalence of chronic diseases, the new drugs in pipeline in mental health sector, and availability of advanced healthcare ...Read More »
The study of chemical processes involving metabolites is called as metabolomics. The field of metabolomics study the chemical fingerprints left behind by biological (cellular) processes. Some of the important healthcare applications of metabolomics include lead compound discovery, lead c...Read More »
Global gonorrhea diagnostic market is expected to witness a significant growth during the forecast period owing to the growing prevalence of the disease worldwide and unmet need in the faster diagnosis tools. According to the U.S. Center for Disease Control and Prevention (CDC), prevalen...Read More »
The global small molecule targeted cancer therapy is expected to be a lucrative market due to its high adoption rates, minimal adverse effects, and high incidence rates of cancer. Patent expiration of the known drug, Glivec of Novartis, is expected to act as an opportunity for manufactur...Read More »
Global endocrinology drugs market is expected to witness lucrative growth over the forecast period owing to increasing prevalence of endocrine diseases. These diseases include endocrine gland associated disorders such as Addison’s disease, gigantism, goiter, Cushing’s syndrom...Read More »
Global anti-counterfeit pharmaceuticals and cosmetics packaging market is expected to grow over the next six years owing to increasing rules and regulations and government initiatives to protect consumers from the use of harmful products. Personal care and cosmetic products are the top p...Read More »
Global spinal fusion bone graft substitutes market is expected to grow substantially owing to increasing demand for minimally invasive surgeries coupled with growing geriatric population, which is correlated with the rising rates of conditions such as Degenerative Disc Disease (DDD), Kyp...Read More »
Global anti-cancer drug market is expected to grow on account of increasing multiple cancer incidences especially in developed economies. Anti-cancer drug market revenues are expected to increase by 50% in the next five years owing to favorable regulatory scenario mainly in the U.S.As per American Cancer Society, nu...Read More »
The global cancer vaccine drug pipeline market is estimated to grow at a CAGR exceeding 27% from 2015 to 2022. Rising vaccines usage combined with other therapies is expected to drive market growth over the forecast period. Growing occurrence of different types of cancer and the introduc...Read More »
Global glioblastoma multiforme treatment market is expected to witness significant growth over the forecast period owing to the rising incidence of oncology diseases and rising geriatric population base. According to U.S. National Cancer Institute GBM is considered as the most aggressive...Read More »
Global combination drugs diagnostic market is expected to witness exponential growth over the coming seven years due to greater efficiency attached to combination diagnosis and accelerated approval of drugs by the regulating authority. In addition, rising geriatric population base, impro...Read More »